Publications by authors named "Jose A Karam"

100Publications

Sarcomatoid renal cell carcinoma: biology, natural history and management.

Nat Rev Urol 2020 Oct 13. Epub 2020 Oct 13.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-020-00382-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551522PMC
October 2020

Cytoreductive Nephrectomy in Patients Presenting With Advanced Disease: Have We Finally Answered the Question?

Cancer J 2020 Sep/Oct;26(5):382-389

From the Department of Urology, University of Texas, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000470DOI Listing
September 2020

Survival following cytoreductive nephrectomy: a comparison of existing prognostic models.

BJU Int 2020 Jul 4. Epub 2020 Jul 4.

Departments of , Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.15160DOI Listing
July 2020

Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma.

Urol Clin North Am 2020 Aug 11;47(3):329-343. Epub 2020 Jun 11.

Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1373, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2020.04.010DOI Listing
August 2020

Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy.

Cancer 2020 Sep 9;126(17):3950-3960. Epub 2020 Jun 9.

Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32991DOI Listing
September 2020

EDITORIAL COMMENT.

Urology 2020 02;136:175

The University of Texas, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.08.059DOI Listing
February 2020

PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.

Urol Oncol 2020 05 18;38(5):496-505. Epub 2019 Dec 18.

Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2019.11.010DOI Listing
May 2020

Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer.

Eur Urol Oncol 2019 Mar 29. Epub 2019 Mar 29.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.01.014DOI Listing
March 2019

Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology.

Curr Opin Urol 2019 09;29(5):521-525

Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000661DOI Listing
September 2019

Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study.

Int J Cancer 2020 04 5;146(7):1836-1840. Epub 2019 Jul 5.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32534DOI Listing
April 2020

Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?

Eur Urol Oncol 2019 07 18;2(4):365-378. Epub 2019 May 18.

Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.04.007DOI Listing
July 2019

Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management.

Eur Urol Focus 2019 11 28;5(6):949-957. Epub 2019 Apr 28.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24054569193012
Publisher Site
http://dx.doi.org/10.1016/j.euf.2019.04.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815690PMC
November 2019

Integrated transcriptomic-genomic tool Texomer profiles cancer tissues.

Nat Methods 2019 05 15;16(5):401-404. Epub 2019 Apr 15.

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41592-019-0388-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337246PMC
May 2019

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

Cancer Cell 2019 02;35(2):204-220.e9

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.01.006DOI Listing
February 2019

Surgical Management of Advanced Kidney Cancer: The Role of Cytoreductive Nephrectomy and Lymphadenectomy.

J Clin Oncol 2018 Oct 29:JCO2018790246. Epub 2018 Oct 29.

Hiten D. Patel and Mohamad E. Allaf, Johns Hopkins University School of Medicine, Baltimore, MD; Jose A. Karam, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.79.0246
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.79.0246DOI Listing
October 2018

Surgical Complications of Presurgical Systemic Therapy for Renal Cell Carcinoma: A Systematic Review.

Kidney Cancer 2017 Nov 27;1(2):115-121. Epub 2017 Nov 27.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/KCA-170016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179118PMC
November 2017

Conditional survival of patients with small renal masses undergoing active surveillance.

BJU Int 2019 03 27;123(3):447-455. Epub 2018 Aug 27.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14486DOI Listing
March 2019

Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Eur J Surg Oncol 2018 09 5;44(9):1439-1445. Epub 2018 Jun 5.

Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2018.05.026DOI Listing
September 2018

Salvage topical therapy for upper tract urothelial carcinoma.

World J Urol 2018 Dec 26;36(12):2027-2034. Epub 2018 May 26.

Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2349-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261784PMC
December 2018

Adjuvant therapy for advanced renal cell carcinoma.

Expert Rev Anticancer Ther 2018 07 2;18(7):663-671. Epub 2018 May 2.

a Department of Urology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1469980DOI Listing
July 2018

Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes.

Urology 2018 Jun 22;116:114-119. Epub 2018 Mar 22.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2018.03.017DOI Listing
June 2018

Editorial Comment.

Authors:
Jose A Karam

J Urol 2018 06 16;199(6):1432. Epub 2018 Mar 16.

The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.11.154DOI Listing
June 2018

Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.

World J Urol 2018 Jul 27;36(7):1093-1101. Epub 2018 Feb 27.

Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2241-7DOI Listing
July 2018

Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.

BMC Genomics 2017 Oct 3;18(Suppl 6):678. Epub 2017 Oct 3.

Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, 7000 Fannin St., Suite 820, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12864-017-4026-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629613PMC
October 2017

Editorial Comment.

J Urol 2018 01 22;199(1):52. Epub 2017 Sep 22.

Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.04.125DOI Listing
January 2018

Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.

J Urol 2018 02 20;199(2):393-400. Epub 2017 Sep 20.

Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.09.072DOI Listing
February 2018

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.

Eur Urol Focus 2016 Jun 9;2(2):204-209. Epub 2015 Dec 9.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2015.11.007DOI Listing
June 2016

Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.

J Urol 2017 10 12;198(4):810-816. Epub 2017 Apr 12.

Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.04.066DOI Listing
October 2017

Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment.

Eur Urol 2017 08 27;72(2):171-174. Epub 2017 Mar 27.

Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.03.005DOI Listing
August 2017

Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.

J Urol 2017 08 6;198(2):281-288. Epub 2017 Mar 6.

Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.03.011DOI Listing
August 2017

Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.

Clin Genitourin Cancer 2017 06 18;15(3):363-370. Epub 2017 Jan 18.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.01.010DOI Listing
June 2017

Nephrometry scoring systems: valuable research tools, but can they be applied in daily clinical practice?

BJU Int 2017 03;119(3):364-365

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.13716
Publisher Site
http://dx.doi.org/10.1111/bju.13716DOI Listing
March 2017

Study of the Kidney Tumor-Parenchymal Interface after Neoadjuvant Treatment with Axitinib for Locally Advanced Clear Cell Renal Cell Carcinoma: Matched Analysis from a Phase II Trial.

J Urol 2017 03 25;197(3 Pt 1):559-565. Epub 2016 Sep 25.

Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.09.081DOI Listing
March 2017

Cytoreductive nephrectomy for metastatic renal cell carcinoma.

Clin Adv Hematol Oncol 2016 Sep;14(9):696-703

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
September 2016

Biomarkers in Genitourinary Cancers: Blazing the Path Forward.

Eur Urol 2017 02 14;71(2):247-248. Epub 2016 Sep 14.

Department of Cancer Biology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.09.011DOI Listing
February 2017

Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma.

J Clin Oncol 2016 11;34(32):3825-3826

Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Jose A. Karam, University of Texas MD Anderson Cancer Center, Houston, TX; Paulo Bergerot, Federal University of Sao Paulo, São Paulo, Brazil; Neeraj Agarwal, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.3572DOI Listing
November 2016

Author reply.

Urology 2016 Jan;87:222-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2015.07.072DOI Listing
January 2016

The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma.

Ther Adv Urol 2016 Apr 20;8(2):130-41. Epub 2015 Nov 20.

Department of Urology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287215612962DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772353PMC
April 2016

Secondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases.

Hum Pathol 2016 06 1;52:55-60. Epub 2016 Feb 1.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2015.12.028DOI Listing
June 2016

Management of the Incidental Adrenal Mass.

Eur Urol Focus 2016 Feb 3;1(3):223-230. Epub 2016 Feb 3.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2015.12.006DOI Listing
February 2016

Cytoreductive surgery in the era of targeted molecular therapy.

Transl Androl Urol 2015 Jun;4(3):301-9

Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.04.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708236PMC
June 2015

Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.

Urol Oncol 2016 Apr 18;34(4):167.e9-16. Epub 2015 Nov 18.

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.10.011DOI Listing
April 2016

Positive Margins after Radical Nephrectomy with Venous Thrombectomy: Controversies and Treatment Options.

J Urol 2016 Feb 14;195(2):241-2. Epub 2015 Nov 14.

Department of Urology, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.11.018DOI Listing
February 2016

Metastatic renal cell carcinoma: Contending with a sea change in therapy.

Urol Oncol 2015 Dec;33(12):507-8

Department of Medical Oncology, University of Calgary, Tom Baker Cancer Center, Calgary, AB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.10.005DOI Listing
December 2015

Surgical considerations for patients with metastatic renal cell carcinoma.

Urol Oncol 2015 Dec 3;33(12):528-37. Epub 2015 Nov 3.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.10.003DOI Listing
December 2015

Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules.

Eur Urol 2016 Feb 14;69(2):352-60. Epub 2015 Sep 14.

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.08.053DOI Listing
February 2016

Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.

BJU Int 2016 Jun 5;117(6B):E87-94. Epub 2015 Oct 5.

Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13268DOI Listing
June 2016

Role of targeted therapy in combination with surgery in renal cell carcinoma.

Int J Urol 2016 Jan 4;23(1):5-12. Epub 2015 Aug 4.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/iju.12891DOI Listing
January 2016